BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 11095969)

  • 1. Role of NAD(+) in the deacetylase activity of the SIR2-like proteins.
    Landry J; Slama JT; Sternglanz R
    Biochem Biophys Res Commun; 2000 Nov; 278(3):685-90. PubMed ID: 11095969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases.
    Borra MT; Langer MR; Slama JT; Denu JM
    Biochemistry; 2004 Aug; 43(30):9877-87. PubMed ID: 15274642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry.
    Sauve AA; Schramm VL
    Biochemistry; 2003 Aug; 42(31):9249-56. PubMed ID: 12899610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD(+)-dependent Sir2 histone/protein deacetylases.
    Zhao K; Harshaw R; Chai X; Marmorstein R
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8563-8. PubMed ID: 15150415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.
    Avalos JL; Bever KM; Wolberger C
    Mol Cell; 2005 Mar; 17(6):855-68. PubMed ID: 15780941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose.
    Tanner KG; Landry J; Sternglanz R; Denu JM
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14178-82. PubMed ID: 11106374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogues and 32P-NAD.
    Du J; Jiang H; Lin H
    Biochemistry; 2009 Apr; 48(13):2878-90. PubMed ID: 19220062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.
    Imai S; Armstrong CM; Kaeberlein M; Guarente L
    Nature; 2000 Feb; 403(6771):795-800. PubMed ID: 10693811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemistry of gene silencing: the mechanism of NAD+-dependent deacetylation reactions.
    Sauve AA; Celic I; Avalos J; Deng H; Boeke JD; Schramm VL
    Biochemistry; 2001 Dec; 40(51):15456-63. PubMed ID: 11747420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural identification of 2'- and 3'-O-acetyl-ADP-ribose as novel metabolites derived from the Sir2 family of beta -NAD+-dependent histone/protein deacetylases.
    Jackson MD; Denu JM
    J Biol Chem; 2002 May; 277(21):18535-44. PubMed ID: 11893743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence assay of SIRT protein deacetylases using an acetylated peptide substrate and a secondary trypsin reaction.
    Marcotte PA; Richardson PL; Guo J; Barrett LW; Xu N; Gunasekera A; Glaser KB
    Anal Biochem; 2004 Sep; 332(1):90-9. PubMed ID: 15301953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coupling of histone deacetylation to NAD breakdown by the yeast silencing protein Sir2: Evidence for acetyl transfer from substrate to an NAD breakdown product.
    Tanny JC; Moazed D
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):415-20. PubMed ID: 11134535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assays for characterization of the Sir2 family of NAD(+)-dependent deacetylases.
    Borra MT; Denu JM
    Methods Enzymol; 2004; 376():171-87. PubMed ID: 14975305
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity.
    Frye RA
    Biochem Biophys Res Commun; 1999 Jun; 260(1):273-9. PubMed ID: 10381378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Sir2 protein family: A novel deacetylase for gene silencing and more.
    Shore D
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14030-2. PubMed ID: 11114164
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of nicotinamide inhibition and transglycosidation by Sir2 histone/protein deacetylases.
    Jackson MD; Schmidt MT; Oppenheimer NJ; Denu JM
    J Biol Chem; 2003 Dec; 278(51):50985-98. PubMed ID: 14522996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIR2: the biochemical mechanism of NAD(+)-dependent protein deacetylation and ADP-ribosyl enzyme intermediates.
    Sauve AA; Schramm VL
    Curr Med Chem; 2004 Apr; 11(7):807-26. PubMed ID: 15078167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conserved enzymatic production and biological effect of O-acetyl-ADP-ribose by silent information regulator 2-like NAD+-dependent deacetylases.
    Borra MT; O'Neill FJ; Jackson MD; Marshall B; Verdin E; Foltz KR; Denu JM
    J Biol Chem; 2002 Apr; 277(15):12632-41. PubMed ID: 11812793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases.
    Landry J; Sutton A; Tafrov ST; Heller RC; Stebbins J; Pillus L; Sternglanz R
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5807-11. PubMed ID: 10811920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism-based inhibition of Sir2 deacetylases by thioacetyl-lysine peptide.
    Smith BC; Denu JM
    Biochemistry; 2007 Dec; 46(50):14478-86. PubMed ID: 18027980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.